OPTIONS Precision Spectra™ Neurostimulator System for the Treatment of Chronic Intractable Pain of the Trunk and/or Limbs.
Year: 2013
Type: Device
Phase: N/A
Indication: Back and/or Leg Pain, Chronic Trunk and/or Limb Pain
An investigation into the therapeutic effect of electrical impulses with short pulse (SP) width on pain relief and quality of the spinal cord stimulation (SCS) in patients with intractable back and / or leg pain.
Year: 2013
Type: Device
Phase: N/A
Indication: Back and/or Leg Pain
BURST Pre-Market Clinical Study.
Year: 2014
Type: Device
Phase: Pre-Market
Indication: Back and/or Leg Pain
A feasibility study evaluating the Saluda SCS system incorporating feedback control using Evoked Compound Action Potentials (ECAP) to aid in the accurate positioning of Spinal Cord Stimulation (SCS) leads.
Year: 2014
Type: Device
Phase: Pre-Market
Indication: Back and/or Leg Pain, Chronic Trunk and/or Limb Pain
Investigation of the ReActiv8® Implantable Stimulation System for Chronic Low Back Pain (ReActiv8-A).
Year: 2014
Type: Device
Phase: Pre-Market
Indication: Back and/or Leg Pain
Avalon: A study to evaluate the safety and performance of a new Spinal Cord Stimulation System using automatic control to treat patients with chronic pain.
Year: 2016
Type: Device
Phase: Pre-Market
Indication: Back and/or Leg Pain, Chronic Trunk and/or Limb Pain, Neck / Upper Limb Pain
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain (ReActiv8-B).
Year: 2017
Type: Device
Phase: Pre-Market
Indication: Back and/or Leg Pain
A Prospective, Single-Blinded, Dose-Response Study of SCS Therapy using Subthreshold Waveform Patterns in Patients with Chronic Neuropathic Low Back Pain.
Year: 2018
Type: Device
Phase: N/A
Indication: Back and/or Leg Pain
A Prospective, Multicentre Study of Low Dose Targeted Drug Delivery (TDD) for Chronic Back Pain Patients who have Failed Spinal Cord Stimulation.
Year: 2019
Type: Device
Phase: N/A
Indication: Back and/or Leg Pain
Buffered GEnipin Microinvasive Device for Treatment of Low Back Pain from Degenerative Disc Disease – CE Marking Safety and Efficacy Study (GEM-SE).
